Industry Reports
Novo Nordisk increased operating profit by 27% in 2010
Organic sales growth of 19% driven by Victoza®, NovoRapid® and Levemir® Sales increased by 19% in Danish kroner and by 13% in local currencies. Gross margin improved by 1.2 percentage points in Danish kroner to 80.8% in 2010, reflecting...
Industry Reports
Pfizer Reports Fourth-Quarter and Full-Year 2010 Results
Pfizer Inc.reported financial results for fourth-quarter and full-year 2010. Since the acquisition of Wyeth was completed on October 15, 2009, fourth-quarter and full-year 2009 results reflect the legacy Wyeth operations from the acquisition date through Pfizer’s domestic and international...
Industry Reports
Innovation drives Novartis to double-digit growth for 2010
Novartis achieved strong financial results in 2010 -Net sales up 14% (+14% in constant currencies, or cc) to USD 50.6 billion. Solid sales growth in fourth quarter, operating income impacted by one-offs and A(H1N1) pandemic flu vaccine sales in...
Industry Reports
Genzyme Financial Recovery Continues in Fourth Quarter
Genzyme Corp. reported that preliminary fourth-quarter revenue grew 23 percent to $1.15 billion from $938 million in the fourth quarter of 2009. For the year, revenue was $4.1 billion compared with $4.0 billion in 2009. Fourth-quarter revenue from the...
Industry Reports
IMS Health Forecasts Global Pharmaceutical Market Growth of 5-7 Percent in 2011, Reaching $880 Billion
The value of the global pharmaceutical market is expected to grow 5-7 percent in 2011, to US$880 billion, compared with a 4-5 percent pace this year, according to IMS Health. The forecast, included in the latest release of IMS...
Industry Reports
BioMimetic Therapeutics Reports 2010 Third Quarter Earnings Results
BioMimetic Therapeutics, Inc. reported its financial results as of and for the three and nine months ended September 30, 2010. For the three months ended September 30, 2010, the Company reported a net loss of $7.8 million, or $0.29...
Industry Reports
GlaxoSmithKline announced third quarter results-Net Sales growth of 14% compared to the previous quarter
GlaxoSmithKline Pharmaceuticals Limited has announced its financial results for the third quarter ended 30th September 2010. The Company has posted a Net Sales growth of 14% compared to the previous quarter, while Profit Before Tax and before Exceptional Items...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
